Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.5B |
| FY2017, ended Dec 31, 2017 | $20.1B |
| FY2018, ended Dec 31, 2018 | $27.0B |
| FY2019, ended Dec 31, 2019 | $32.8B |
| FY2020, ended Dec 31, 2020 | $31.8B |
| FY2021, ended Dec 31, 2021 | $47.0B |
| FY2022, ended Dec 31, 2022 | $52.2B |
| FY2023, ended Dec 31, 2023 | $56.1B |
| FY2024, ended Dec 31, 2024 | $67.9B |
| FY2025, ended Dec 31, 2025 | $76.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $74.5B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.59B |
| FY2017, ended Dec 31, 2017 | $8.98B |
| FY2018, ended Dec 31, 2018 | $9.54B |
| FY2019, ended Dec 31, 2019 | $10.1B |
| FY2020, ended Dec 31, 2020 | $11.6B |
| FY2021, ended Dec 31, 2021 | $13.3B |
| FY2022, ended Dec 31, 2022 | $14.4B |
| FY2023, ended Dec 31, 2023 | $15.8B |
| FY2024, ended Dec 31, 2024 | $16.7B |
| FY2025, ended Dec 31, 2025 | $17.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $18.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.04B | $1.03B |
| FY2017, ended Dec 31, 2017 | $1.13B | $938M |
| FY2018, ended Dec 31, 2018 | $1.32B | $1.22B |
| FY2019, ended Dec 31, 2019 | $1.39B | $1.08B |
| FY2020, ended Dec 31, 2020 | $1.75B | $2.37B |
| FY2021, ended Dec 31, 2021 | $2.16B | $2.76B |
| FY2022, ended Dec 31, 2022 | $2.17B | $2.58B |
| FY2023, ended Dec 31, 2023 | $2.35B | $2.03B |
| FY2024, ended Dec 31, 2024 | $2.39B | $2.03B |
| FY2025, ended Dec 31, 2025 | $2.54B | $1.59B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.65B | $2.16B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $147M |
| FY2017, ended Dec 31, 2017 | $46.3M |
| FY2018, ended Dec 31, 2018 | $31.3M |
| FY2019, ended Dec 31, 2019 | $40.4M |
| FY2020, ended Dec 31, 2020 | $466M |
| FY2021, ended Dec 31, 2021 | $362M |
| FY2022, ended Dec 31, 2022 | $109M |
| FY2023, ended Dec 31, 2023 | $279M |
| FY2024, ended Dec 31, 2024 | $130M |
| FY2025, ended Dec 31, 2025 | $194M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $262M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.90B |
| FY2017, ended Dec 31, 2017 | $2.98B |
| FY2018, ended Dec 31, 2018 | $3.42B |
| FY2019, ended Dec 31, 2019 | $3.89B |
| FY2020, ended Dec 31, 2020 | $4.12B |
| FY2021, ended Dec 31, 2021 | $3.83B |
| FY2022, ended Dec 31, 2022 | $4.37B |
| FY2023, ended Dec 31, 2023 | $5.57B |
| FY2024, ended Dec 31, 2024 | $5.52B |
| FY2025, ended Dec 31, 2025 | $6.02B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.01B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 41.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.37B |
| FY2017, ended Dec 31, 2017 | 1.26B |
| FY2018, ended Dec 31, 2018 | 1.18B |
| FY2019, ended Dec 31, 2019 | 1.12B |
| FY2020, ended Dec 31, 2020 | 1.05B |
| FY2021, ended Dec 31, 2021 | 999M |
| FY2022, ended Dec 31, 2022 | 927M |
| FY2023, ended Dec 31, 2023 | 886M |
| FY2024, ended Dec 31, 2024 | 859M |
| FY2025, ended Dec 31, 2025 | 838M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 809M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.51B | $18.9M |
| FY2017, ended Dec 31, 2017 | $2.17B | $19.4M |
| FY2018, ended Dec 31, 2018 | $1.71B | $20.2M |
| FY2019, ended Dec 31, 2019 | $1.43B | $21.9M |
| FY2020, ended Dec 31, 2020 | $2.09B | $22.7M |
| FY2021, ended Dec 31, 2021 | $2.48B | $24.7M |
| FY2022, ended Dec 31, 2022 | $3.28B | $26.5M |
| FY2023, ended Dec 31, 2023 | $3.15B | $27.5M |
| FY2024, ended Dec 31, 2024 | $2.08B | $28.9M |
| FY2025, ended Dec 31, 2025 | $2.10B | $35.1M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.35B | $33.8M |
Valuation
At current price- Market Cap
- $72.7B
- P/E
- 27.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.9×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 19.0×
Growth
Trailing 12 months- Revenue (TTM)
- $18.6B
- Revenue Growth YoY
- 8.5%
- Revenue CAGR 3Y
- 7.3%
- Revenue CAGR 5Y
- 8.9%
- EPS Growth YoY
- 12.9%
- Net Income Growth YoY
- 9.4%
Profitability
Trailing 12 months- Gross Margin
- 51.6%
- Operating Margin
- 19.6%
- Net Margin
- 14.3%
- FCF Margin
- 11.6%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $2.65B
- EPS (diluted)
- $3.15
- EBITDA
- $4.17B
- Operating Income
- $3.63B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $262M
- Total Debt
- $7.01B
- Net Debt
- $6.75B
- Total Assets
- $17.4B
- Total Liabilities
- $19.2B
- Shareholders' Equity
- −$1.84B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.29B
- Capital Expenditure
- $1.13B
- Free Cash Flow
- $2.16B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.54
Every ratio is calculated from the company’s reported figures.